Semi-Annual Statement Of Income And Retained Earnings

Kringle Pharma,Inc. - Filing #7290853

Concept 2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-817,882,000 JPY
-888,762,000 JPY
Non-operating income
Non-operating income
62,920,000 JPY
43,431,000 JPY
Non-operating expenses
Non-operating expenses
JPY
7,330,000 JPY
Ordinary profit (loss)
-754,961,000 JPY
-852,660,000 JPY
Profit (loss) before income taxes
-754,961,000 JPY
-852,660,000 JPY
Income taxes - current
1,491,000 JPY
1,490,000 JPY
Profit (loss)
-756,453,000 JPY
-756,453,000 JPY
-756,453,000 JPY
-756,453,000 JPY
-854,151,000 JPY
-854,151,000 JPY
-854,151,000 JPY
-854,151,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.